Management of heavy menstrual bleeding in general practice

Current Medical Research and Opinion

Volumn 28, Issue 9, 2012, Pages 1517-1525

  Fox, Kenneth E ^a  

^a Family Medical Associates Research Department   (United States)

Author keywords

Abnormal uterine bleeding; Dysfunctional uterine bleeding; Endometrial; Menorrhagia treatment; Primary care; Women's health

Indexed keywords

DANAZOL; ETAMSYLATE; GESTAGEN; GONADORELIN AGONIST; LEVONORGESTREL; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

ABDOMINAL PAIN; ADENOMYOSIS; ALOPECIA; AMENORRHEA; ANOVULATION; ARTERIOVENOUS MALFORMATION; BLOATING; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BONE DENSITY; BREAKTHROUGH BLEEDING; BREAST TENDERNESS; COLOR VISION; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG WITHDRAWAL; DYSMENORRHEA; DYSPAREUNIA; ENDOCRINE DISEASE; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; FEMALE FERTILITY; FLUID RETENTION; GENERAL PRACTICE; GENERAL PRACTITIONER; HEADACHE; HIRSUTISM; HORMONAL THERAPY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPERTENSION; HYPOTHYROIDISM; HYSTERECTOMY; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; JAUNDICE; LIBIDO DISORDER; LIVER FUNCTION; MASTALGIA; MENORRHAGIA; MENSTRUAL IRREGULARITY; METRORRHAGIA; MOOD CHANGE; MOOD DISORDER; MYOMECTOMY; NAUSEA; NIGHT SWEAT; OVARY POLYCYSTIC DISEASE; PELVIC EXAMINATION; PREMENSTRUAL DYSPHORIC DISORDER; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; SLEEP DISORDER; THROMBOSIS; THYROID FUNCTION TEST; TRANSVAGINAL ECHOGRAPHY; UNITED STATES; UNSPECIFIED SIDE EFFECT; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS MYOMA; VAGINAL DRYNESS; VISUAL ACUITY; WEIGHT GAIN;

CONTRACEPTIVES, ORAL; FEMALE; GENERAL PRACTICE; HISTORY, 18TH CENTURY; HUMANS; MENORRHAGIA;

EID: 84866700975     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.716030     Document Type: Review

References (50)

1. Hallberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-51
2. Vilos GA, Lefebvre G, Graves GR. Guidelines for the management of abnormal uterine bleeding. J Obstet Gynaecol Canada 2001;106:1-6
3. Ministry of Health Malaysia and Academy of Medicine Malaysia. Clinical Practice: Management of Menorrhagia. 2004:1-17
4. Marret H, Fauconnier A, Chabbert-Buffet N, et al. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 2010;152:133-7
5. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol 2004;190:1224-9
6. National Institute for Health and Clinical Excellence. Heavy menstrual bleeding. Guideline 44. In: National Collaborating Centre for Women's and Children's Health, ed. London, England, 2007
7. Liu Z, Doan QV, Blumenthal P, et al. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007;10:183-94
8. Fraser IS, Langham S, Uhl-Hochgraeber K. The health-related quality of life and economic burden of abnormal uterine bleeding: a critical review. Expert Rev Obstet Gynecol 2009;4:179-89
9. Janssen CA, Scholten PC, Heintz AP. Menorrhagia-a search for epidemio-logical risk markers. Maturitas 1997;28:19-25
10. Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3-13
11. Collins J, Crosignani PG. Endometrial bleeding. Hum Reprod Update 2007;13:421-31
12. Shapley M, Jordan K, Croft PR. Why women consult with increased vaginal bleeding: a case-control study. Br J Gen Pract 2002;52:108-13
13. Osei J, Critchley H. Menorrhagia, mechanisms and targeted therapies. Curr Opin Obstet Gynecol 2005;17:411-18
14. Zakherah MS, Sayed GH, El-Nashar SA, et al. Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin. Gynecol Obstet Invest 2011;71:281-4
15. Kuzmina N, Palmblad J, Mints M. Predictive factors for the occurrence of idiopathic menorrhagia: evidence for a hereditary trait. Mol Med Report 2011;4:935-9
16. The Hong Kong College of Obstetricans and Gynaecologists. Guidelines on investigation of women with abnormal uterine bleeding under the age of 40. HKCOG Guidelines 2001:1-7
17. Yarandi F, Izadi-Mood N, Eftekhar Z, et al. Diagnostic accuracy of dilatation and curettage for abnormal uterine bleeding. J Obstet Gynaecol Res 2010;36:1049-52
18. Knol HM, Bogchelman DH, Kluin-Nelemans HC, et al. Routine evaluation and treatment of unexplained menorrhagia: do we consider haemostatic disorders? Eur J Obstet Gynecol Reprod Biol 2010;152:191-4
19. Duckitt K, Collins S. Menorrhagia. Clin Evid (Online) 2008;2008:805
20. Fraser IS, Porte RJ, Kouides PA, et al. A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding. Drug Saf 2008;31:275-82
21. Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf 2004;27:75-90
22. Lethaby A, Irvine GA, Cameron IT. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008;1. Art. No.: CD001016. DOI: 10.1002/14651858.CD001016.pub2
23. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet 2001;72:263-71
24. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579-82
25. Hurskainen R, Grenman S, Komi I, et al. Diagnosis and treatment of menor-rhagia. Acta Obstet Gynecol Scand 2007;86:749-57
26. Matteson KA, Anderson BL, Pinto SB, et al. Practice patterns and attitudes about treating abnormal uterine bleeding: a national survey of obstetricians and gynecologists. Am J Obstet Gynecol 2011;205:321.e1-8
27. Farquhar C, Brown J. Oral contraceptive pill for heavy menstrual bleeding. Cochrane Database Syst Rev 2009;4. Art. No.: CD000154. DOI: 10.1002/14651858.CD000154.pub2.
28. Fraser IS, Romer T, Parke S, et al. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial. Hum Reprod 2011;26:2698-708
29. Jensen JT, Parke S, Mellinger U, et al. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecol 2011;117:777-87
30. Bhattacharya S, Middleton LJ, Tsourapas A, et al. Hysterectomy, endometrial ablation and Mirena(R) for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technol Assess 2011;15:1-252
31. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;4. Art. No.: CD000400. DOI: 10.1002/14651858.CD000400.pub2
32. Edlund MN. Nonhormonal medications for treatment of heavy menstrual bleeding. J Women's Health (Larchmt) 2011;20:1645-53
33. Rybo G. Tranexamic acid therapy: effective treatment in heavy menstrual bleeding. Clinical update on safety. Ther Adv 1991;4:1-8
34. Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003;63:1417-33
35. Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116:865-75
36. Freeman EW, Lukes A, Vandrie D, et al. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding. Am J Obstet Gynecol 2011;205:319.e1-7
37. Muse K, Lukes AS, Gersten J, et al. Long-term evaluation of safety and health-related quality of life in women with heavy menstrual bleeding treated with oral tranexamic acid. Womens Health (Lond Engl) 2011;7: 699-707
38. Berntorp E, Follrud C, Lethagen S. No increased risk of venous thrombosis in women taking tranexamic acid. Thromb Haemost 2001;86:714-15
39. Practice Committee of American Society for Reproductive Medicine. Indications and options for endometrial ablation. Fertil Steril 2008;90:S236-40
40. Lethaby A, Hickey M, Garry R, Penninx J. Endometrial resection/ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2009;4. Art. No.: CD001501. DOI: 10.1002/14651858.CD001501.pub3
41. Royal College of Obstetricians and Gynaecologists. National Heavy Menstrual Bleeding Audit: First Annual Report. London, UK: RCOG Press, 2011
42. Longinotti MK, Jacobson GF, Hung YY, et al. Probability of hysterectomy after endometrial ablation. Obstet Gynecol 2008;112:1214-20
43. Hare AA, Olah KS. Pregnancy following endometrial ablation: a review article. J Obstet Gynaecol 2005;25:108-14
44. AlHilli MM, Hopkins MR, Famuyide AO. Endometrial cancer after endometrial ablation: systematic review of medical literature. J Minim Invasive Gynecol 2011;18:393-400
45. Bourdrez P, Bongers MY, Mol BW. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel- releasing intrauterine device, or hysterectomy. Fertil Steril 2004;82:160-6
46. van der Kooij SM, Bipat S, Hehenkamp WJ, et al. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol 2011;205:317.e1-18
47. Hanafi M. Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 2005;105:877-81
48. Yoo EH, Lee PI, Huh CY, et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol 2007;14:690-7
49. Telner DE, Jakubovicz D. Approach to diagnosis and management of abnormal uterine bleeding. Can Fam Physician 2007;53:58-64
50. Bushnell DM, Martin ML, Moore KA, et al. Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life. Curr Med Res Opin 2010;26:2745-55